New Referencing Round Should Cause Further Price Erosion For Drugmakers

The next update to Slovakia's medicine price list is due in April 2010, with the Ministry of Health aiming to reference 90% of marketed products. This update is expected to bring about savings of EUR30mn (US$41mn) over the following 12 months as a result of further price erosion for drugmakers. Here BMI explores Slovakia's pricing and reimbursement environment and its effect on market access for

To read the full article, please choose one of the following options: